Financials data is unavailable for this security.
Cash flow in GBPView more
In 2023, cash reserves at Celadon Pharmaceuticals PLC fell by 3.80m. Cash Flow from Financing totalled 2.51m or 3,348.00% of revenues. In addition the company used 5.97m for operations while cash used for investing totalled 341.00k.
Cash flow per share | -0.1087 |
---|---|
Price/Cash flow per share | -- |
Book value per share | 0.0492 |
---|---|
Tangible book value per share | 0.0441 |
More ▼
Balance sheet in GBPView more
Current ratio | 2.62 |
---|---|
Quick ratio | 2.55 |
Total debt/total equity | 1.49 |
---|---|
Total debt/total capital | 0.5972 |
More ▼